
The Biden administration on Tuesday named the first 10 medicines that will be subject to price negotiations between Medicare and participating drug companies. The list represents the first step in a landmark program aimed at reducing the government’s drug spending, and potentially U.S. drug prices in general. However, six major drug companies are already challenging… read on > read on >